Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis

OBJECTIVE: This study aimed to evaluate safety (infusion‐related reactions [IRRs]) and patient satisfaction (patient‐reported outcomes [PROs]) for at‐home ocrelizumab administration for patients with multiple sclerosis (MS). METHODS: This open‐label study included adult patients with an MS diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrera, Britney, Simpson, Haley, Engebretson, Eric, Sillau, Stefan, Valdez, Brooke, Parra‐González, José, Winger, Ryan C., Epperson, Lou Anne, Banks, Ashley, Pierce, Kathryn, Spotts, Melanie, O'Gean, Katie, Alvarez, Enrique, Gross, Robert, Piquet, Amanda L., Schreiner, Teri, Corboy, John R., Pei, Jinglan, Vollmer, Timothy L., Nair, Kavita V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109340/
https://www.ncbi.nlm.nih.gov/pubmed/36811392
http://dx.doi.org/10.1002/acn3.51745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109340/
https://www.ncbi.nlm.nih.gov/pubmed/36811392
http://dx.doi.org/10.1002/acn3.51745

Ejemplares similares